Intas Intacef Tazo 562.50 mg Injection – Cefepime & Tazobactam Injection

Intas Intacef Tazo 562.5mg Injection | Cefepime 500mg & Tazobactam 62.5mg | Broad-Spectrum Antibiotic for Bacterial Infections | 1 Vial

Sale price  Rs. 83.00 Regular price  Rs. 85.00
Skip to product information
Intas Intacef Tazo 562.50 mg Injection – Cefepime & Tazobactam Injection

Intas Intacef Tazo 562.5mg Injection | Cefepime 500mg & Tazobactam 62.5mg | Broad-Spectrum Antibiotic for Bacterial Infections | 1 Vial

Sale price  Rs. 83.00 Regular price  Rs. 85.00 Unit price Rs. 83.00 each

Intas Intacef Tazo 562.5mg Injection | Cefepime 500mg & Tazobactam 62.5mg (1 Vial)

Intas Intacef Tazo is a broad-spectrum injectable antibiotic combining Cefepime 500mg (fourth-generation cephalosporin) and Tazobactam 62.5mg (beta-lactamase inhibitor). Tazobactam protects Cefepime from bacterial beta-lactamase enzymes, extending its antibacterial spectrum against resistant gram-positive and gram-negative bacteria.

Note: verify exact indications and species suitability from the product label or package insert.

Composition (Per Vial)

  • Cefepime: 500mg — fourth-generation cephalosporin; broad-spectrum bactericidal cephalosporin antibiotic
  • Tazobactam: 62.5mg — beta-lactamase inhibitor; protects Cefepime from enzymatic degradation by resistant bacteria

Key Benefits

  • Broad-spectrum antibacterial coverage against gram-positive and gram-negative pathogens
  • Tazobactam extends efficacy against beta-lactamase-producing resistant strains
  • Fourth-generation cephalosporin — effective against a wide range of susceptible organisms
  • Injectable vial format for parenteral administration

Indications

  • Respiratory tract infections caused by susceptible bacteria
  • Urinary tract infections caused by susceptible gram-negative organisms
  • Skin and soft tissue infections
  • Intra-abdominal infections
  • Serious and complicated bacterial infections caused by resistant organisms

Dosage & Administration

  • Administer parenterally as directed — dose and duration based on species, body weight, and severity of infection
  • For parenteral (IV/IM) use only — administer under veterinary supervision
  • Complete the full prescribed course

Safety Information

  • Prescription-only medication — use strictly under veterinary supervision
  • Use with caution in animals with known renal impairment
  • Not effective against viral infections
  • Keep out of reach of children
  • Store in a cool, dry place away from direct sunlight

You may also like